About Jason Efstathiou, MD, Dphil
Dr. Efstathiou is Professor of Radiation Oncology at Harvard Medical School (HMS) and Director of the Genitourinary (GU) Division in the Department of Radiation Oncology and Clinical Co-Director of The Claire and John Bertucci Center for GU Cancers at Massachusetts General Hospital. He holds a BS from Yale University, MD from HMS, DPhil from the University of Oxford, and completed his residency training in the Harvard Radiation Oncology Program.
His busy and robust clinical practice focuses on treatment of patients with prostate, bladder, testicular and other urologic cancers, as well as proton beam therapy and brachytherapy. Delivery of first-rate excellent patient care is a focus and his commitment to patient care, service and mentorship has been recognized as honoree for the MGH Cancer Center's "The One Hundred", as nominee for the Brian A. McGovern Award for Clinical Excellence, as Health Professional of the Game (for the Patriots and Red Sox), as a MGH Mentor with Distinction, and as recipient of the 2021 A. Clifford Barger Excellence in Mentoring Award from HMS.
He is an internationally recognized leader in the field of GU malignancies and Radiation Oncology. His research has informed clinical guidelines and made novel contributions to organ preservation for bladder cancer and technology assessment of advanced/emerging therapies for prostate cancer including proton therapy. He is the recipient of significant grant funding and serves as the Principal Investigator of multi-center, NCI-sponsored, randomized trials in prostate and bladder cancer. He also remains active in evaluating biomarkers for bladder and prostate cancer outcomes. Other projects of his include the development of web-based patient decision aids/support tools, integrating Patient Reported Outcome Measures (PROMs) into practice, evaluating the multidisciplinary approach to cancer care, and global oncology outreach efforts with Botswana.
He lectures nationally and internationally and holds leadership positions in Oncology including within the cooperative groups (NRG Oncology - Vice-Chair GU Steering Committee and Bladder Lead), professional societies (ASTRO, ASCO, ABR, ACRO), and the National Cancer Institute (NCI). He also serves on patient advocacy organizations including the Bladder Cancer Advocacy Network (BCAN) and on the Board of Directors for the Massachusetts Prostate Cancer Coalition (MPCC).
Departments, Centers, & Programs:
Clinical Interests:
- Prostate cancer
- Bladder cancer
- Testicular, penile and genito-urinary cancers
- Kidney cancer
- Ureteral / Urethral cancer
- Penile cancer
- Proton Beam Therapy
- Brachytherapy (radioactive seeds)
Treats:
- Adult
Locations
Radiation Oncology
55 Fruit Street
Boston, MA 02114-2606
Phone: 617-726-5866
Fax: 617-726-3603
Medical Education
- MD, Harvard Medical School
- PHD, University of Oxford
- Residency, Brigham and Women's Hospital
American Board Certifications
- Radiation Oncology, American Board of Radiology
Accepted Insurance Plans
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- MassHealth
- Medicare
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
#1 Research Hospital in America
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.